Updated Jul 16, 2026
Baranick Brian is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $265K.
Brian Baranick is an executive at Exact Sciences Corp, where he serves as Executive Vice President and General Manager of Precision Oncology. He has been involved in the company's efforts to provide innovative cancer screening and diagnostic solutions.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-23 | EXAS | EXACT SCIENCES CORP | D — Derivative transaction | 795 | — | |
| 2026-03-23 | EXAS | EXACT SCIENCES CORP | D — Derivative transaction | 137.2K | — | |
| 2026-03-23 | EXAS | EXACT SCIENCES CORP | A — Grant or award | 33.3K | $0.00 | |
| 2025-12-30 | EXAS | EXACT SCIENCES CORP | F — Tax withholding / forfeiture | 14.9K | $101.59 | $1.52M |
| 2025-12-30 | EXAS | EXACT SCIENCES CORP | A — Grant or award | 29.4K | $0.00 | |
| 2025-12-30 | EXAS | EXACT SCIENCES CORP | F — Tax withholding / forfeiture | 10.5K | $101.82 | $1.06M |
| 2025-12-30 | EXAS | EXACT SCIENCES CORP | A — Grant or award | 20.6K | $0.00 | |
| 2025-12-30 | EXAS | EXACT SCIENCES CORP | F — Tax withholding / forfeiture | 21.6K | $101.82 | $2.20M |
| 2025-12-30 | EXAS | EXACT SCIENCES CORP | A — Grant or award | 42.5K | $0.00 | |
| 2025-12-30 | EXAS | EXACT SCIENCES CORP | F — Tax withholding / forfeiture | 8.2K | $101.82 | $830K |
| 2025-12-30 | EXAS | EXACT SCIENCES CORP | M — Option exercise | 16.1K | $0.00 | |
| 2025-12-30 | EXAS | EXACT SCIENCES CORP | F — Tax withholding / forfeiture | 14.6K | $101.82 | $1.49M |
| 2025-12-30 | EXAS | EXACT SCIENCES CORP | M — Option exercise | 28.8K | $0.00 | |
| 2025-12-30 | EXAS | EXACT SCIENCES CORP | F — Tax withholding / forfeiture | 7.5K | $101.82 | $768K |
| 2025-12-30 | EXAS | EXACT SCIENCES CORP | M — Option exercise | 14.8K | $0.00 | |
| 2025-12-30 | EXAS | EXACT SCIENCES CORP | F — Tax withholding / forfeiture | 4.8K | $101.82 | $489K |
| 2025-12-30 | EXAS | EXACT SCIENCES CORP | M — Option exercise | 9.4K | $0.00 | |
| 2025-12-30 | EXAS | EXACT SCIENCES CORP | F — Tax withholding / forfeiture | 2.0K | $101.82 | $205K |
| 2025-12-30 | EXAS | EXACT SCIENCES CORP | M — Option exercise | 4.0K | $0.00 | |
| 2025-11-06 | EXAS | EXACT SCIENCES CORP | S — Open-market sale | 2.9K | $70.08 | $200K |
Brian Baranick is an executive at Exact Sciences Corp, where he serves as Executive Vice President and General Manager of Precision Oncology. He has been involved in the company's efforts to provide innovative cancer screening and diagnostic solutions.…
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($265K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Baranick Brian profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.